Nuwellis Inc (ASX:SHC) Stock News, Headlines & Updates
Nuwellis Inc Stock News from GuruFocus
- 1
Aug 23, 2024
Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Marketwired • 8:00am
Aug 14, 2024
Nuwellis Inc (NUWE) Q2 2024 Earnings Call Transcript Highlights: Revenue Growth and Operational Efficiency Amid Challenges
GuruFocus Research • 3:00pm
Q2 2024 Nuwellis Inc Earnings Call Transcript
GuruFocus Research • 2:10pm
Aug 13, 2024
Nuwellis, Inc. Announces Second Quarter 2024 Financial Results
Marketwired • 8:00am
Aug 08, 2024
Nasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to Conditions
Marketwired • 8:00am
Jul 26, 2024
Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's QUELIMMUNE™ Therapy at Cincinnati Children's
Marketwired • 8:00am
Jul 24, 2024
Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules
Marketwired • 8:00am
Jul 23, 2024
Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024
Marketwired • 4:00pm
Jul 17, 2024
Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children's
Marketwired • 8:00am
Jul 09, 2024
New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference
Marketwired • 8:00am
Jun 26, 2024
Nuwellis Announces Reverse Stock Split
Marketwired • 8:00am
Jun 25, 2024
Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™
Marketwired • 8:00am
Jun 06, 2024
Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase
Marketwired • 8:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news